ergotamine has been researched along with Heart Valve Diseases in 21 studies
*Heart Valve Diseases: Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE). [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.52) | 18.7374 |
| 1990's | 7 (33.33) | 18.2507 |
| 2000's | 8 (38.10) | 29.6817 |
| 2010's | 4 (19.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumann, MH; Hufeisen, SJ; McBride, A; Rauser, L; Roth, BL; Rothman, RB; Savage, JE | 1 |
| Kantartzis, M; Lazopoulos, G; Papaioannou, G | 1 |
| Badhwar, V; Cavalcante, JL; Ohori, NP; Patel, SM | 1 |
| McCorvy, JD; Roth, BL | 1 |
| Bednarski, M; Nowak, G; Sapa, J; Zajdel, P | 1 |
| Bhattacharyya, S; Davar, J; Mikhailidis, DP; Schapira, AH | 1 |
| el Allaf, D; Goujon-Dubois, J | 1 |
| Bagheri, H; Montastruc, JL; Pathak, A | 1 |
| Gross Kastanovitz, E; Jiménez Cabrera, F; Llorens León, R; Martínez Quintana, E; Nieto Lago, V; Redondo Martínez, E | 1 |
| Schachter, M | 1 |
| Bijl, M; van den Brink, RB | 1 |
| Dupont, E; Egeblad, H; Ostergaard, K; Poulsen, SH; Rasmussen, VG; Safikhany, G | 1 |
| Faber, L | 1 |
| Daenen, W; Flameng, W; Hendrikx, M; Van Dorpe, J | 1 |
| Hesse, H; Hufnagel, G; Maisch, B; Wilke, A | 1 |
| Grinberg, M; Halpern, A; Leite, CC; Rossi, EG; Sbano, JC | 1 |
| Creutzig, A | 1 |
| Edwards, WD; Nicholson, WJ; Redfield, MM; Tajik, AJ | 1 |
| Bresnahan, DR; Danielson, GK; Edwards, WD; Hauck, AJ; Mullany, CJ | 1 |
| Graham, JR; LeCompte, PR; Sadowsky, NL; Suby, HI | 1 |
6 review(s) available for ergotamine and Heart Valve Diseases
| Article | Year |
|---|---|
Structure and function of serotonin G protein-coupled receptors.
Topics: Allosteric Site; Animals; Ergotamine; GTP-Binding Proteins; Heart Valve Diseases; Humans; Migraine Disorders; Models, Molecular; Protein Conformation; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT2B; Receptors, Serotonin; Serotonin Receptor Agonists; Signal Transduction; Vasoconstrictor Agents | 2015 |
Ergotamine and nicergoline - facts and myths.
Topics: Ergotamine; Heart Valve Diseases; Humans; Nicergoline | 2015 |
Drug-induced fibrotic valvular heart disease.
Topics: Antiparkinson Agents; Appetite Depressants; Cabergoline; Dexfenfluramine; Dopamine Agonists; Drug Monitoring; Ergolines; Ergotamine; Fenfluramine; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Methysergide; Migraine Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Patient Selection; Pergolide; Receptors, Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Vasoconstrictor Agents | 2009 |
Cardiac valvulopathy.
Topics: Antiparkinson Agents; Echocardiography, Doppler, Color; Ergotamine; Fenfluramine; Heart Valve Diseases; Humans; Serotonin Agents | 2005 |
Aortic and mitral valve disease induced by ergotamine therapy for migraine: a case report and review of the literature.
Topics: Adult; Aortic Valve; Caffeine; Drug Combinations; Ergotamine; Female; Heart Valve Diseases; Humans; Migraine Disorders; Mitral Valve | 1996 |
Mitral and aortic valve disease associated with ergotamine therapy for migraine. Report of two cases and review of literature.
Topics: Adult; Aortic Valve; Ergotamine; Female; Heart Valve Diseases; Humans; Middle Aged; Migraine Disorders; Mitral Valve | 1990 |
15 other study(ies) available for ergotamine and Heart Valve Diseases
| Article | Year |
|---|---|
Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications.
Topics: Dose-Response Relationship, Drug; Ergotamine; Fenfluramine; Heart Valve Diseases; Humans; Methylergonovine; Norfenfluramine; Receptors, Serotonin; Serotonin Antagonists | 2000 |
Cardiac surgery for ergotamine-induced multivalvular heart disease.
Topics: Aortic Valve Insufficiency; Caffeine; Cardiac Valve Annuloplasty; Cell Proliferation; Drug Combinations; Echocardiography, Doppler, Color; Ergotamine; Female; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Heart Valves; Humans; Middle Aged; Mitral Valve Insufficiency; Myofibroblasts; Serotonin 5-HT2 Receptor Agonists; Treatment Outcome; Tricuspid Valve Insufficiency | 2013 |
From headache to heartache: ergotamine-induced aortic and mitral valvulopathy.
Topics: Aortic Valve; Aortic Valve Insufficiency; Ergotamine; Female; Heart Valve Diseases; Humans; Middle Aged; Migraine Disorders; Mitral Valve; Mitral Valve Insufficiency; Mitral Valve Stenosis; Ultrasonography | 2013 |
[Clinical case of the month. Triple valvular dysfunction associated with long-term ergotamine therapy].
Topics: Adrenergic alpha-Agonists; Aortic Valve; Ergotamine; Female; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Middle Aged; Migraine Disorders; Mitral Valve; Tricuspid Valve | 2003 |
[Pergolide treatment and cardiac valve pathology: the continuing saga of ergotamine-induced fibrosis].
Topics: Dopamine Agonists; Ergotamine; Fibrosis; Heart Diseases; Heart Valve Diseases; Humans; Pergolide; Vasoconstrictor Agents | 2004 |
[Valvular heart disease associated with ergotamine].
Topics: Adult; Analgesics, Non-Narcotic; Ergotamine; Female; Heart Valve Diseases; Humans; Male; Middle Aged | 2005 |
Images in clinical medicine. Four artificial heart valves.
Topics: Aged; Analgesics, Non-Narcotic; Ergotamine; Female; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Migraine Disorders | 2005 |
Ergotamine-derived dopamine agonists and left ventricular function in Parkinson patients: systolic and diastolic function studied by conventional echocardiography, tissue Doppler imaging, and two-dimensional speckle tracking.
Topics: Aged; Analysis of Variance; Biomarkers; Diastole; Dopamine Agonists; Echocardiography; Echocardiography, Doppler, Pulsed; Ergotamine; Female; Heart Valve Diseases; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Parkinson Disease; Retrospective Studies; Systole; Ventricular Dysfunction, Left; Ventricular Function, Left | 2008 |
[Ergotamine-induced heart valve fibrosis].
Topics: Ergotamine; Fibrosis; Heart Valve Diseases; Heart Valves; Humans | 1993 |
Mitral, aortic and tricuspid valvular heart disease associated with ergotamine therapy for migraine.
Topics: Aortic Valve; Ergotamine; Ergotism; Female; Heart Failure; Heart Valve Diseases; Humans; Middle Aged; Migraine Disorders; Mitral Valve; Tricuspid Valve | 1997 |
[The link between drug use and heart valve disease].
Topics: Appetite Depressants; Ergotamine; Heart Valve Diseases; Humans; Methysergide; Serotonin Antagonists | 1998 |
Drugs for migraine.
Topics: Caffeine; Clonidine; Drug Synergism; Ergotamine; Heart Valve Diseases; Humans; Methysergide; Migraine Disorders; Mitral Valve Insufficiency; Propranolol; Pulmonary Fibrosis | 1976 |
[Ergotamine-induced heart valve fibrosis and coronary microangiopathy?].
Topics: Coronary Disease; Dihydroergotamine; Ergotamine; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Male; Middle Aged; Mitral Valve Insufficiency | 1992 |
Valve disease associated with ergot alkaloid use: echocardiographic and pathologic correlations.
Topics: Adult; Echocardiography; Ergot Alkaloids; Ergotamine; Female; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Male; Methysergide; Middle Aged; Mitral Valve Insufficiency; Mitral Valve Stenosis | 1992 |
Fibrotic disorders associated with methysergide therapy for headache.
Topics: Adult; Aged; Aortic Diseases; Aortic Valve Insufficiency; Ergotamine; Female; Headache; Heart Valve Diseases; Humans; Hydronephrosis; Male; Methysergide; Middle Aged; Migraine Disorders; Pulmonary Fibrosis; Retroperitoneal Fibrosis; Serotonin; Spondylitis, Ankylosing; Urography | 1966 |